rs35353912

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_004187.5(KDM5C):​c.1794C>T​(p.Pro598Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00306 in 1,210,529 control chromosomes in the GnomAD database, including 4 homozygotes. There are 1,171 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P598P) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0021 ( 0 hom., 56 hem., cov: 23)
Exomes 𝑓: 0.0032 ( 4 hom. 1115 hem. )

Consequence

KDM5C
NM_004187.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: 0.806

Publications

3 publications found
Variant links:
Genes affected
KDM5C (HGNC:11114): (lysine demethylase 5C) This gene is a member of the SMCY homolog family and encodes a protein with one ARID domain, one JmjC domain, one JmjN domain and two PHD-type zinc fingers. The DNA-binding motifs suggest this protein is involved in the regulation of transcription and chromatin remodeling. Mutations in this gene have been associated with X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
KDM5C Gene-Disease associations (from GenCC):
  • syndromic X-linked intellectual disability Claes-Jensen type
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant X-53201926-G-A is Benign according to our data. Variant chrX-53201926-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 94871.
BP7
Synonymous conserved (PhyloP=0.806 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00207 (233/112381) while in subpopulation NFE AF = 0.00368 (196/53269). AF 95% confidence interval is 0.00326. There are 0 homozygotes in GnomAd4. There are 56 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 56 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KDM5CNM_004187.5 linkc.1794C>T p.Pro598Pro synonymous_variant Exon 13 of 26 ENST00000375401.8 NP_004178.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KDM5CENST00000375401.8 linkc.1794C>T p.Pro598Pro synonymous_variant Exon 13 of 26 1 NM_004187.5 ENSP00000364550.4

Frequencies

GnomAD3 genomes
AF:
0.00207
AC:
233
AN:
112329
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000519
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000565
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00218
Gnomad FIN
AF:
0.00130
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00368
Gnomad OTH
AF:
0.000664
GnomAD2 exomes
AF:
0.00179
AC:
329
AN:
183514
AF XY:
0.00184
show subpopulations
Gnomad AFR exome
AF:
0.000456
Gnomad AMR exome
AF:
0.000182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00175
Gnomad NFE exome
AF:
0.00320
Gnomad OTH exome
AF:
0.00176
GnomAD4 exome
AF:
0.00316
AC:
3475
AN:
1098148
Hom.:
4
Cov.:
30
AF XY:
0.00307
AC XY:
1115
AN XY:
363502
show subpopulations
African (AFR)
AF:
0.000455
AC:
12
AN:
26402
American (AMR)
AF:
0.000341
AC:
12
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.000103
AC:
2
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.000979
AC:
53
AN:
54147
European-Finnish (FIN)
AF:
0.00118
AC:
48
AN:
40532
Middle Eastern (MID)
AF:
0.00169
AC:
7
AN:
4137
European-Non Finnish (NFE)
AF:
0.00380
AC:
3198
AN:
842038
Other (OTH)
AF:
0.00310
AC:
143
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
138
276
415
553
691
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00207
AC:
233
AN:
112381
Hom.:
0
Cov.:
23
AF XY:
0.00162
AC XY:
56
AN XY:
34547
show subpopulations
African (AFR)
AF:
0.000518
AC:
16
AN:
30902
American (AMR)
AF:
0.000565
AC:
6
AN:
10628
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2651
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3586
South Asian (SAS)
AF:
0.00219
AC:
6
AN:
2744
European-Finnish (FIN)
AF:
0.00130
AC:
8
AN:
6173
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00368
AC:
196
AN:
53269
Other (OTH)
AF:
0.000656
AC:
1
AN:
1524
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000829
Hom.:
2
Bravo
AF:
0.00179
EpiCase
AF:
0.00294
EpiControl
AF:
0.00338

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 05, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Uncertain:1
Feb 20, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic paraplegia Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 13, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
3.4
DANN
Benign
0.62
PhyloP100
0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35353912; hg19: chrX-53231108; COSMIC: COSV104428165; API